# Sensus Healthcare, Inc. (SRTS)

> Source: Nexqual · https://nexqual.com/SRTS · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Sensus Healthcare, Inc. (SRTS), nexqual.com/SRTS" · informational, not investment advice.

**Price:** USD 2.77 (-3.15% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 2.86 · day 2.71–2.87 · 52w 2.66–5.49 · market cap $45.6M · NCM

## Key facts
- Analysts: Buy (mean 1.75 on a 1–5 scale) (4 analysts), mean target USD 5.38 (range 4–6).
- Total return with dividends: 1Y -16.3% vs S&P 500 +18.1%; 5Y -30.6% vs S&P 500 +85.1%.
- Next earnings: 2026-11-05, EPS estimate USD -0.04, revenue estimate $6.6M.

## Analysts
Consensus Buy (mean 1.75 on a 1–5 scale), 4 analysts; mean target USD 5.38 (low 4, high 6).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-14 | Lake Street | Target lowered | Buy | $4.5 → $4 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | -16.3% | -30.6% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -16.4% | -7.0% |
| Volatility (annualized) | 65.2% | 82.5% |
| Max drawdown | -49.3% (Jan 2026→Jun 2026) | -87.3% (Aug 2022→Nov 2023) |

## Peers (Medical Devices)
ESTA (Establishment Labs Holdings Inc) USD 61.36 +4.98% · ALMR (Alamar Biosciences, Inc.) USD 27.42 +16.58% · INSP (Inspire Medical Systems, Inc.) USD 70.12 +1.83% · BFLY (Butterfly Network, Inc.) USD 7.85 -3.09% · AXGN (AxoGen, Inc.) USD 35.63 -1.49% · UFPT (UFP Technologies, Inc.) USD 297.19 +0.99%

## More
Full page: https://nexqual.com/SRTS · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt